共 239 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 68 394-424
[2]
Ferlay J(2004)The changing face of low-risk prostate cancer: trends in clinical presentation and primary management J Clin Oncol. 22 2141-2149
[3]
Soerjomataram I(2017)Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Lancet 389 815-822
[4]
Siegel RL(2001)Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer J Urol. 166 104-110
[5]
Torre LA(2005)Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy BJU Int. 96 999-1004
[6]
Jemal A(2014)A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial Eur Urol. 66 343-351
[7]
Cooperberg MR(2012)Three-tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers Eur Urol. 62 902-909
[8]
Lubeck DP(2020)Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer J Urol 203 706-712
[9]
Meng MV(2019)Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer Cochrane Database Syst Rev 4 CD012663-1777
[10]
Mehta SS(2018)MRI-targeted or standard biopsy for prostate-cancer diagnosis N Engl J Med 378 1767-109